Phase I clinical trial of a recombinant oncolytic virus injection combined with PD-1 antibody-based gene therapy for recurrent head and neck cancer in China: An open-label study
在中国开展的重组溶瘤病毒注射联合PD-1抗体基因疗法治疗复发性头颈癌的I期临床试验：一项开放标签研究
期刊:Virus Research
影响因子:2.7
doi:10.1016/j.virusres.2025.199639
Zhu, Siyu; Zhong, Qi; Zhang, Yang; Hou, Lizhen; Ma, Hongzhi; Feng, Ling; Shen, Xixi; Chen, Jiaming; He, Yurong; Lyu, Jingwen; Wang, Tiantian; Zhao, Rui; Li, Jingfeng; Fang, Jugao; He, Shizhi
